Neurosense Therapeutics Ltd (NRSN) is around the middle of the Biotechnology industry according to InvestorsObserver. NRSN received an overall rating of 53, which means that it scores higher than 53 percent of all stocks. Neurosense Therapeutics Ltd also achieved a score of 50 in the Biotechnology industry, putting it above 50 percent of Biotechnology stocks. Biotechnology is ranked 18 out of the 148 industries.
NRSN has an Overall Score of 53. Find out what this means to you and get the rest of the rankings on NRSN!